Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 9,189 | Dovepress* | 4,652 | 3,320+ | 1,345 | 7,972 |
| PubMed Central* | 0 | 1,217 | 467 | 1,217 | |
| Totals | 4,652 | 4,537 | 1,812 | 9,189 | |
|
*Since 10 November 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar